The cardiovascular complications in COVID-19: Focus on acute cardiac injury.
Acute cardiac injury
Antihypertensive treatment
COVID-19
Cardiovascular complications
Coronavirus disease 2019
Hypertension
Prognosis
Journal
Pakistan journal of medical sciences
ISSN: 1682-024X
Titre abrégé: Pak J Med Sci
Pays: Pakistan
ID NLM: 100913117
Informations de publication
Date de publication:
Historique:
entrez:
9
6
2021
pubmed:
10
6
2021
medline:
10
6
2021
Statut:
ppublish
Résumé
At the end of 2019 a novel coronavirus was identified in Wuhan, China. The disease caused by the severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) was designated COVID-19 (corona virus disease 2019) by the World Health Organization in early 2020. Up to 80% of patients with COVID-19 experience mild symptoms with severe or critical disease occurring in the remaining 20%. Severe disease is manifested by the development of pneumonia, hypoxia and radiographic lung involvement while critical disease indicates multiorgan involvement with significant respiratory or cardiac compromise. The current estimated case fatality rate from COVID-19 is approximately 1%. Epidemiological studies have shown that advanced age, male gender, previous chronic lung disease, cardiovascular and kidney disease, obesity and diabetes are risk factors for the severity of disease course. In the current focused review, we present an overview of the acute cardiovascular complications of COVID-19, their detection and impact upon prognosis.
Identifiants
pubmed: 34104187
doi: 10.12669/pjms.37.3.4063
pii: PJMS-37-908
pmc: PMC8155435
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
908-912Informations de copyright
Copyright: © Pakistan Journal of Medical Sciences.
Déclaration de conflit d'intérêts
Conflict of Interest: None.
Références
Prog Cardiovasc Dis. 2020 May - Jun;63(3):390-391
pubmed: 32169400
JAMA Cardiol. 2020 Nov 01;5(11):1265-1273
pubmed: 32730619
Circulation. 2020 Jun 9;141(23):1903-1914
pubmed: 32297796
JACC Cardiovasc Imaging. 2020 Nov;13(11):2287-2299
pubmed: 32654963
J Am Coll Cardiol. 2020 Nov 3;76(18):2043-2055
pubmed: 33121710
Eur Heart J Cardiovasc Imaging. 2020 Sep 1;21(9):949-958
pubmed: 32556199
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687
pubmed: 32352535
J Am Coll Cardiol. 2020 Aug 4;76(5):533-546
pubmed: 32517963
Future Cardiol. 2021 Nov;17(8):1321-1326
pubmed: 33876965
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Cardiovasc Res. 2020 Aug 1;116(10):1688-1699
pubmed: 32293003
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet Infect Dis. 2020 Jul;20(7):773
pubmed: 32171390
Eur Heart J. 2020 May 14;41(19):1858
pubmed: 32227120
Circulation. 2020 Jun 9;141(23):1930-1936
pubmed: 32243205
Pak J Med Sci. 2020 Nov-Dec;36(7):1634-1639
pubmed: 33235588
Hypertension. 2020 Oct;76(4):1104-1112
pubmed: 32673499
J Card Fail. 2020 Jul;26(7):626-632
pubmed: 32544622
Eur Heart J. 2020 May 14;41(19):1839-1851
pubmed: 32405641
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
J Am Coll Cardiol. 2020 Jun 23;75(24):3078-3084
pubmed: 32272153
Int J Cardiol. 2021 Mar 15;327:251-258
pubmed: 33242508
Pak J Med Sci. 2020 Nov-Dec;36(7):1732-1736
pubmed: 33235606
J Am Heart Assoc. 2020 Sep 15;9(18):e016807
pubmed: 32806998
J Hypertens. 2021 Jul 1;39(7):1282-1292
pubmed: 33687179
Hypertension. 2020 Aug;76(2):366-372
pubmed: 32564693
Int J Cardiol. 2020 Jul 15;311:116-121
pubmed: 32291207
Aging (Albany NY). 2020 Apr 8;12(7):6049-6057
pubmed: 32267833
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Am Heart J. 2020 Aug;226:29-44
pubmed: 32497913
Heart. 2020 Oct;106(19):1503-1511
pubmed: 32737124
BMJ Case Rep. 2020 Aug 19;13(8):
pubmed: 32816835
J Hypertens. 2020 Aug;38(8):1613-1614
pubmed: 32472780